EMERYVILLE, Calif., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced financial results for the second quarter ended June 30, 2013.
" During the second quarter, we continued to ramp up our farnesene production volume at our production facility in Brotas, Brazil. We achieved record renewable product sales during the quarter and continued to execute on our collaboration strategy with our partners, all the while maintaining lower operating expenses," said John Melo, Amyris President & CEO.
" We have also secured an agreement with our two leading shareholders for $60 million in funding, which will provide us with the necessary resources and financial flexibility to achieve Amyris's business objectives," Melo added.BUSINESS HIGHLIGHTS Below are some highlights from our activities during the second quarter of 2013. Farnesene Production
- Continued production and commercial shipments of farnesene from our facility located adjacent to the Paraíso sugarcane mill in Brotas, São Paulo.
- Successful ramp up of farnesene production allowed early exit from a higher-cost contract manufacturing facility.
- Renewable product sales of $4.2 million during the quarter were up 40% over previous quarter and 84% higher than same period in 2012.
- Quarterly revenue increase led by sales of renewable emollient (Neossance® Squalane), confirming cosmetic formulators' shift from shark and olive oil-derived squalane to Amyris sugarcane-derived squalane.
- Agreement with Firmenich to begin commercial production of a high-value fragrance oil molecule later this year.
- Second successful demonstration flight with Amyris-Total renewable jet fuel at Paris Air Show.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts